The serum from a patient with human MOG-IgG shows a widespread... | Download Scientific Diagram
Therapeutic management of MOG-IgG associated disorders. *Benefit–risk... | Download Scientific Diagram
Refining cell-based assay to detect MOG-IgG in patients with central nervous system inflammatory diseases - ScienceDirect
Neurological update: MOG antibody disease | SpringerLink
IJMS | Free Full-Text | Cells to the Rescue: Emerging Cell-Based Treatment Approaches for NMOSD and MOGAD
Neuromyelitis optica MOG-IgG causes reversible lesions in mouse brain | Acta Neuropathologica Communications | Full Text
Corrected CSF/Serum MOG-IgG Index, Lesion Location, and Clinical... | Download Scientific Diagram
Selective Depletion of Antigen-Specific Antibodies for the Treatment of Demyelinating Disease - ScienceDirect
Beyond Aquaporin and MOG- Novel brain reactive antibodies and B cell responses in Neuromyelitis optica spectrum disorders | Else Kröner-Fresenius-Stiftung
Recent developments in MOG-IgG associated neurological disorders | Semantic Scholar
Detection of MOG-IgG by cell-based assay: moving from discovery to clinical practice | SpringerLink
Myelin oligodendrocyte glycoprotein immunoglobulin G‐associated disease: An overview - Fujihara - 2018 - Clinical and Experimental Neuroimmunology - Wiley Online Library
Frontiers | Serum and Cerebrospinal Fluid Biomarkers in Neuromyelitis Optica Spectrum Disorder and Myelin Oligodendrocyte Glycoprotein Associated Disease
Low mortality rate in a large cohort of myelin oligodendrocyte glycoprotein antibody disease (MOGAD) - Lotan - 2023 - Annals of Clinical and Translational Neurology - Wiley Online Library
Figure MRI of anti-MOG-IgG-associated myelitis | Download Scientific Diagram
Anti-MOG autoantibodies pathogenicity in children and macaques demyelinating diseases | Journal of Neuroinflammation | Full Text
Clinical Characteristics and Treatment of MOG-IgG–Associated Optic Neuritis | SpringerLink
Neuromyelitis optica MOG-IgG causes reversible lesions in mouse brain | Acta Neuropathologica Communications | Full Text
Frontiers | Myelin Oligodendrocyte Glycoprotein Antibody-Associated Disorders: Toward a New Spectrum of Inflammatory Demyelinating CNS Disorders?
Brain Sciences | Free Full-Text | Coexistence of Myelin Oligodendrocyte Glycoprotein Immunoglobulin G and Neuronal or Glial Antibodies in the Central Nervous System: A Systematic Review
High titers of myelin oligodendrocyte glycoprotein antibody are only observed close to clinical events in pediatrics - Multiple Sclerosis and Related Disorders
Brain lesions caused by MOG-IgG and AQP4-IgG. Mice received... | Download Scientific Diagram
MOG-IgG in NMO and related disorders: a multicenter study of 50 patients. Part 1: Frequency, syndrome specificity, influence of disease activity, long-term course, association with AQP4-IgG, and origin – topic of research
Identification of a pathogenic antibody response to native myelin oligodendrocyte glycoprotein in multiple sclerosis | PNAS
Does MOG Ig-positive AQP4-seronegative opticospinal inflammatory disease justify a diagnosis of NMO spectrum disorder? | Neurology Neuroimmunology & Neuroinflammation
Myelin-oligodendrocyte glycoprotein antibody-associated disease - The Lancet Neurology
